Telomir Pharmaceuticals, Inc.
TELO
Last
$1.12
Day
-2.6%
1y
-40.4%
5y
-77.0%
52w
-45.0%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-0929d
EMA 21
1.18
EMA 50
1.18
EMA 200
1.34
20d high
-27.2%
5y high
-94.4%
5y range
1th
Positions held
Your positionsTELO isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-16
Hold
avoid
Signal
Strong Sell
Target
$1.30
Stop
$1.03
Stop distance
8.0%
Target vs last
+16.1%
Fundamentals
| Market cap | $84.66M | Enterprise value | $74.06M | Trailing P/E | — | Forward P/E | -4.11 |
| PEG | — | Price / book | 15.75 | Beta | -0.30 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -2.1% | ROA | -122.8% | Debt / equity | 0.03 |
| Current ratio | 16.14 | Free cash flow | -$3.07M | Analyst recommendation | none | Mean target | $4.00 |
| 52w high | $1.82 | 52w low | $0.89 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$1.7M | -$1.0M | -$2.1M | -$1.1M | -$5.1M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$1.8M | -$1.0M | -$2.1M | -$1.1M | -$5.1M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M |
| Op margin | — | — | — | — |
| Net income | -$10.4M | -$16.5M | -$13.1M | -$0.9M |
| Gross margin | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating income | -$10.5M | -$12.2M | -$3.9M | -$0.9M |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
Price (daily)
Full chart · RSI · MACD · patternsTELO · daily-8.0% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin